Kezar Life Sciences, Inc. - Common Stock (NQ:KZR)

7.290 UNCHANGED

Last Price Updated: 4:00 PM EDT, May 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Kezar Life Sciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

June 09, 2023

From Kezar Life Sciences

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 08, 2023

Via Benzinga

Kezar Life Sciences to Participate in the Jefferies Healthcare Conference

May 31, 2023

From Kezar Life Sciences, Inc.

Via Business Wire

Kezar Life Sciences: Q1 Earnings Insights ↗

May 11, 2023

Via Benzinga

Kezar Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update

May 11, 2023

From Kezar Life Sciences, Inc.

Via Business Wire

Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

April 05, 2023

From Kezar Life Sciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 16, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

April 03, 2023

On Monday, 76 companies set new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023 ↗

March 16, 2023

Via Benzinga

Kezar Life Sciences Reports Fourth Quarter and Year End 2022 Financial Results and Provides Business Update

March 14, 2023

From Kezar Life Sciences, Inc.

Via Business Wire

Kezar Life Sciences to Change Virtual R&D Day Date to March 15, 2023

March 13, 2023

From Kezar Life Sciences, Inc.

Via Business Wire

Kezar Life Sciences to Host Virtual R&D Day on March 22, 2023

March 06, 2023

From Kezar Life Sciences, Inc.

Via Business Wire

Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

March 03, 2023

From Kezar Life Sciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 01, 2023

Via Benzinga

Kezar Life Sciences to Participate in the Cowen 43rd Annual Health Care Conference

March 01, 2023

From Kezar Life Sciences, Inc.

Via Business Wire

Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

February 06, 2023

From Kezar Life Sciences, Inc.

Via Business Wire

Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

January 13, 2023

From Kezar Life Sciences, Inc.

Via Business Wire

Kezar Life Sciences to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 04, 2023

From Kezar Life Sciences, Inc.

Via Business Wire

Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

December 07, 2022

From Kezar Life Sciences, Inc.

Via Business Wire

Kezar Life Sciences Presents Positive Complete Results from the MISSION Phase 2 Trial Evaluating Zetomipzomib in Lupus Nephritis at the American College of Rheumatology Convergence 2022

November 14, 2022

From Kezar Life Sciences, Inc.

Via Business Wire

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

November 11, 2022

From Kezar Life Sciences, Inc.

Via Business Wire

Kezar Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update

November 10, 2022

From Kezar Life Sciences, Inc.

Via Business Wire

Kezar Life Sciences to Participate in Two Upcoming Investor Conferences

November 09, 2022

From Kezar Life Sciences, Inc.

Via Business Wire

Kezar Life Sciences Presents Positive Complete Results from the MISSION Phase 2 Trial Evaluating Zetomipzomib in Lupus Nephritis at ASN’s Kidney Week 2022 Annual Meeting

November 03, 2022

From Kezar Life Sciences, Inc.

Via Business Wire

Kezar Life Sciences to Present Complete Results from the Phase 2 MISSION Trial of Zetomipzomib in Patients with Lupus Nephritis at the American Society of Nephrology’s Kidney Week 2022 Annual Meeting

October 14, 2022

From Kezar Life Sciences, Inc.

Via Business Wire

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

October 06, 2022

From Kezar Life Sciences, Inc.

Via Business Wire

Why Kezar Life Sciences Shares Are Volatile After Hours ↗

October 03, 2022

Kezar Life Sciences Inc (NASDAQ: KZR) shares are trading higher in Monday's after-hours session after the company announced that it has received clearance of its Investigational New Drug (IND)...

Via Benzinga

Kezar Life Sciences Receives FDA Clearance of IND for Zetomipzomib for the Treatment of Autoimmune Hepatitis

October 03, 2022

From Kezar Life Sciences, Inc.

Via Business Wire

Kezar Life Sciences to Present Complete Results from the Phase 2 MISSION Trial of Zetomipzomib in Patients with Lupus Nephritis at the American College of Rheumatology Convergence 2022

September 29, 2022

From Kezar Life Sciences, Inc.

Via Business Wire

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

September 02, 2022

From Kezar Life Sciences, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.